iSpecimen Inc. (ISPC) vs Inotiv, Inc. (NOTVQ)
iSpecimen Inc. and Inotiv, Inc. are both Diagnostics & Research companies. iSpecimen Inc. is the larger, with a market value of $3.1M against $2.8M — 1.1× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −92.1%. Inotiv, Inc. has the higher net margin (−17.1% vs −2,449.0%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 19 metrics below, Inotiv, Inc. leads on 10 and iSpecimen Inc. on 9.
Valuation
Profitability
| Metric | ISPC | NOTVQ | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | (108.26%) | 22.94% | 50.89% |
| Operating margin | (2,020.05%) | (9.48%) | (8.57%) |
| Net margin | (2,449.02%) | (17.14%) | (6.37%) |
| Free cash flow margin | (1,866.61%) | (1.95%) | 0.00% |
| Return on equity | (968.44%) | (74.09%) | (2.92%) |
| Return on assets | (170.09%) | (11.85%) | (6.71%) |
| Return on invested capital | 0.00% | (6.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack